MolPort-001-684-471

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

29 Suppliers, 19 USDMF, 5 CEP/COS, 3 EU WC, 17 NDC API, 12 Listed Suppliers

DEVELOPMENTS

10 Drug(s) in Development

10 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Imports

DOSSIERs // Finished Dosage Forms

169 Dossiers, 119 FDA Orange Book, 13 Europe, 11 Canada, 8 Australia, 4 South Africa, 14 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 0.3MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers, 30 Kerry, 25 Roquette, 21 BASF, 13 Seppic, 12 Microlex e.U, 12 Gangwal Chemicals, 12 Sigachi Industries, 11 Corel Pharma Chem, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 9 Gangwal Healthcare, 9 Actylis, 7 Boai NKY Pharmaceuticals Ltd, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 6 DFE Pharma, 6 Lonza Capsugel, 5 SPI Pharma, 5 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 4 Vasa Pharmachem, 4 Pharmatrans-Sanaq, 4 Prachin Chemical, 3 Nanjing Well Pharmaceutical, 3 Ulanqab Kema New Material, 3 Kima Chemical, 2 Jai Radhe Sales, 2 Rochem International Inc, 2 The Dow Chemical Company, 2 DKSH, 1 Clariant, 1 Pfanstiehl, 1 Nanjing Bold Chemical, 1 ACG Worldwide, 1 Qualicaps, 1 Zhejiang Huakang Pharmaceutical, 1 Aeon Procare, 1 Pharm-RX Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Alcedo Pharmachem

EXCIPIENTS BY APPLICATIONS

68 Fillers, Diluents & Binders, 46 Coating Systems & Additives, 43 Disintegrants & Superdisintegrants, 38 Direct Compression, 27 Granulation, 25 Controlled & Modified Release, 23 Solubilizers, 21 Thickeners and Stabilizers, 17 Taste Masking, 17 Lubricants & Glidants, 13 Parenteral, 13 Co-Processed Excipients, 11 Film Formers & Plasticizers, 10 Chewable & Orodispersible Aids, 7 API Stability Enhancers, 6 Emulsifying Agents, 6 Topical, 5 Empty Capsules, 4 Rheology Modifiers, 4 Vegetarian Capsules, 2 Coloring Agents, 2 Surfactant & Foaming Agents

GLOBAL SALES INFORMATION

56 US Medicaid Prescriptions, 17 Finished Drug Prices

MARKET PLACE

9 APIs, 3 DOSSIERS // FDF

PATENTS

4 US Patents

4 US Patents

ANALYTICAL SOLUTION(s)

2 EDQM Standards, 2 USP Standards, 4 Other Ref. Standards

DIGITAL CONTENT

3 Data Compilation & Company Tracker #PharmaFlow, 31 News

List of USP reference standards related to MolPort-001-684-471

MolPort-001-684-471

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

29 Suppliers

19 USDMF

5 CEP/COS

3 EU WC

17 NDC API

12 Listed Suppliers

DEVELOPMENTS

10 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Imports

DOSSIERs // Finished Dosage Forms

169 Dossiers

119 FDA Orange Book

13 Europe

11 Canada

8 Australia

4 South Africa

14 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 0.3MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers

30 Kerry

25 Roquette

21 BASF

13 Seppic

12 Microlex e.U

12 Gangwal Chemicals

12 Sigachi Industries

11 Corel Pharma Chem

10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

9 Gangwal Healthcare

9 Actylis

7 Boai NKY Pharmaceuticals Ltd

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

6 DFE Pharma

6 Lonza Capsugel

5 SPI Pharma

5 Ideal Cures Pvt Ltd

4 Ingredion Pharma Solutions

4 Vasa Pharmachem

4 Pharmatrans-Sanaq

4 Prachin Chemical

3 Nanjing Well Pharmaceutical

3 Ulanqab Kema New Material

3 Kima Chemical

2 Jai Radhe Sales

2 Rochem International Inc

2 The Dow Chemical Company

2 DKSH

1 Clariant

1 Pfanstiehl

1 Nanjing Bold Chemical

1 ACG Worldwide

1 Qualicaps

1 Zhejiang Huakang Pharmaceutical

1 Aeon Procare

1 Pharm-RX Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

1 Alcedo Pharmachem

EXCIPIENTS BY APPLICATIONS

68 Fillers, Diluents & Binders

46 Coating Systems & Additives

43 Disintegrants & Superdisintegrants

38 Direct Compression

27 Granulation

25 Controlled & Modified Release

TABLET;ORAL - 0.1MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 0.2MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 0.3MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 0.1MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 0.2MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons